A survey of transfusion support strategies for passenger lymphocyte syndrome in minor ABO-mismatched allogeneic hematopoietic stem cell transplantation [0.03%]
次要ABO位点不匹配的allo-HSCT受者输血支持策略的调查研究——PLS防治措施共识报告
Ayda Javanbakht,Brian D Adkins,Ravi Sarode
Ayda Javanbakht
Background: Passenger lymphocyte syndrome (PLS) is a hematologic complication of ABO blood-type minor incompatibility that can occur following both solid-organ and hematopoietic stem cell transplant (HSCT). HSCT patients ...
Transfusion of blood products to neonatal and pediatric extracorporeal membrane oxygenation patients: A prospective, observational study [0.03%]
血制品在新生儿及儿科体外膜式氧合患者中的应用:一项前瞻性观察研究
Rebecca Barton,Suelyn Van Den Helm,Hui Ping Yaw et al.
Rebecca Barton et al.
Study question: To describe the blood product utilization during neonatal and pediatric extracorporeal membrane oxygenation (ECMO) and to determine whether its usage correlates with clinical outcomes of bleeding, thrombos...
The impact of foreign aid and guidance cuts on the developmental progress of transfusion medicine [0.03%]
外援及指导削减对输血医学发展进程的影响
Cees Th Smit Sibinga
Cees Th Smit Sibinga
Therapeutic plasma exchange for refractory Mycoplasma pneumoniae-associated cold agglutinin syndrome: A case report [0.03%]
难治性肺炎支原体相关冷凝集素综合征的血浆置换治疗报告
Alistair Murray,Mischa Covington
Alistair Murray
Background: Cold agglutinin syndrome (CAS) secondary to Mycoplasma pneumoniae typically self-resolves with antimicrobial therapy and supportive care. Therapeutic plasma exchange (TPE) has been described as an adjunct ther...
Case Reports
Transfusion. 2026 Jun 11. DOI:10.1111/trf.70294 2026
Caroline D Culver,Monica S Klein,Josie Finger et al.
Caroline D Culver et al.
Impact of delayed blood donation sample processing and testing on SARS-CoV-2 serological assay results in an evolving pandemic response [0.03%]
延迟的血液样本处理和检测对新冠病毒血清学检测结果的影响——从一场不断发展的疫情应对中得出的经验教训
Marion C Lanteri,Valerie Green,Hasan Sulaeman et al.
Marion C Lanteri et al.
Background: The two largest US blood collection organizations led a multiphased, multicenter nationwide SARS-CoV-2 blood donor-based serosurveillance program. The potential impact of delayed sample processing and prolonge...
Changes in unrelated donor usage for allogeneic hematopoietic cell transplant in Canada: 2013-2023 and identifying priorities in donor selection [0.03%]
加拿大异基因造血细胞移植的无关供者使用变化(2013-2023)及供者选择中的优先事项识别
Tanvir Hasan,Matthew Seftel,Patti Wright et al.
Tanvir Hasan et al.
Background: Factors influencing unrelated donor selection for allogeneic hematopoietic cell transplantation (HCT) continue to shift. To understand current priorities in step-wise donor selection and guide optimal recruitm...
The neurodivergent blood donor: Fairness, discrimination, screening, and behavior [0.03%]
神经多样性献血者:公平性、歧视、筛查和行为
Eamonn Ferguson,Niall OHagan,Richard Mills et al.
Eamonn Ferguson et al.
Background: We broaden the ongoing drive to diversify blood donor panels by proposing and testing a framework to explore neurodivergence and blood donation. Drawing on a range of theoretical perspectives, we predict that ...
Mario Toriello,Stefania Nappo,Stefania Lama et al.
Mario Toriello et al.
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment for various hematopoietic diseases. ABO incompatibility occurs in approximately 30%-40% of allogeneic HSCTs and is classified as major, ...
Continuing Medical Education [0.03%]
继续医学教育
Editorial
Transfusion. 2026 Jun;66(6):1085. DOI:10.1111/trf.70288 2026